SCHEMBL17629993

SCHEMBL17629993

N#Cc1ccc(-c2ccc(-n3ccnc3)cc2)c(F)c1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADH5 P11766 11/20 0.60
PDE2A O00408 1/20 0.50
PDE1A P54750 1/20 0.50
PDE1B Q01064 1/20 0.50
PDE3B Q13370 1/20 0.50
PDE1C Q14123 1/20 0.50
PDE3A Q14432 1/20 0.50
CYP19A1 P11511 1/20 0.48
ALOX15 P16050 3/20 0.47
MEN1 O00255 1/20 0.47
TSHR P16473 1/20 0.47
KMT2A Q03164 1/20 0.47
CYP1A2 P05177 2/20 0.44
CYP3A4 P08684 2/20 0.44
CYP2D6 P10635 2/20 0.44
CYP2C19 P33261 2/20 0.44
HSD17B10 Q99714 2/20 0.44
TDP1 Q9NUW8 1/20 0.44
ADH1B P00325 1/20 0.43
LMNA P02545 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17643381 0.84 PDE2A (0.50) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL17630206 0.84 ADH5 (0.60) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL17643377 0.84 ADH5 (0.60) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL17630034 0.83 ADH5 (0.46) ADH5CYP19A1ALOX15CYP1A2CYP3A4
SCHEMBL17629992 0.81 MEN1 (0.64) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL17630188 0.81 ADH5 (0.59) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL17672965 0.81 MAPK1 (0.42) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL1009532 0.80 LMNA (0.58) ADH5CYP19A1ALOX15MEN1TSHR
SCHEMBL17630180 0.79 ADH5 (0.64) ADH5PDE2APDE1APDE1BPDE3B
SCHEMBL17629932 0.79 ADH5 (0.60) ADH5PDE2APDE1APDE1BPDE3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2016046782-A1 IMIDAZOLE BIARYL COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2016-03-31 WO disclosed
WO-2016046782-A1 IMIDAZOLE BIARYL COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS GLENMARK PHARMACEUTICALS S.A. (CH) 2016-03-31 WO disclosed